After JPM, What Are the Legal Dealmaking Trends to Watch?
After another insightful conference this year, these are some of the key legal deal trends to expect from the health care and life sciences industries in 2023.
Stryker buys Canadian imaging technology firm for $701M
Stryker is shelling out top dollar to buy Novadaq, a maker of fluorescence imaging technologies that allows surgeons to see blood flow in vessels during surgery in real time.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
A healthcare investing prediction: The world becomes fickle
Hey startup CEO: How will you need to think differently about protecting your assets in a way that allows you to build value in the long term?
Healthcare entrepreneurs trust no one (and that’s why they’re brilliant)
There are plenty of good investors out there, but many will pull a Mr. Hyde act to get what they want from healthcare entrepreneurs.
Read the MedCity News survey on corporate venture capital in healthcare
It's time to know more about corporate venture capital because, unlike traditional venture or angel groups, there's much less insight on corporate VCs and their practices.